← United States · All US Insider Profiles

US INSIDER PROFILE · NON-SCORING RESEARCH

GOLDMAN SACHS GROUP INC

10% Owner | Other

Identity: SEC reporting-owner CIK · Reporting-owner CIK: 0000886982

Purchase history

Companies traded
4
Purchases · 12M
6
Purchases · 24M
6
Average purchase
$4.0M
Median purchase
$1.7M
Gross purchase value
$24.0M

Companies: Attovia Therapeutics, Inc. | INFLECTION POINT ACQUISITION CORP. IV | QVC Group, Inc. | Sweetgreen, Inc.

6 SEC accession(s) · 6 joint-owner event(s). Values are reported Form 4 transaction values in USD.

Qualifying purchase disclosures

PublishedCompanyTickerRoleReported valueSEC source
2026-08-28Attovia Therapeutics, Inc.ATTOOther$10.3MOpen filing
2026-08-13Attovia Therapeutics, Inc.ATTOOther$10.3MOpen filing
2026-04-24QVC Group, Inc.QVCGP10% Owner$5.5KOpen filing
2026-04-22QVC Group, Inc.QVCGP10% Owner$5.5KOpen filing
2026-04-09Sweetgreen, Inc.SG10% Owner$3.4MOpen filing
2026-02-26INFLECTION POINT ACQUISITION CORP. IVBACQ10% Owner$45.9KOpen filing

Post-purchase outcomes

Excess return = stock return − S&P 500 ETF (SPY adjusted close) return. Returns start on the first shared trading session on or after publication.

PeriodCompleted eventsPrice coverageHit rateMedian excess returnAverage excess returnWorst excess return
5D2Small Sample33.3% (2/6)100.0% (2/2)+15.3%+15.3%+7.3%
20D2Small Sample33.3% (2/6)50.0% (1/2)+3.0%+3.0%-14.5%
60D0No Data0.0% (0/4)————
120D0No Data0.0% (0/4)————

Research patterns

First purchase in 12M
4/6
Large purchase ≥ $100k
3/6
Cluster buying · 15D
6/6
Buying the dip
0/—

Routine / opportunistic: Not classifiable. These labels never affect the score or ranking.

Small samples remain visible but are not scored. This research enrichment never affects US-v1.1.